Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Common variable immunodeficiency (CVID) is a heterogeneous primary immunodeficiency affecting humoral immunity, predominantly in adults.
• CVID presents with diverse immunological profiles and clinical manifestations, indicating complex underlying mechanisms.
• Recent advances reveal a significant genetic component, with identified mutations contributing to the CVID phenotype.

Purpose of the Study:

• To explore the genetic basis of Common variable immunodeficiency (CVID).
• To understand the role of specific gene mutations in CVID pathogenesis.
• To elucidate the molecular mechanisms underlying humoral immune defects in CVID.

Main Methods:

• Genetic analysis of patients with CVID phenotype.
• Identification and characterization of mutations in genes such as TACI, BAFF-R, CD19, and ICOS.
• Investigation of the functional consequences of these mutations on humoral immunity.

Main Results:

• Four monogenic defects in TACI, BAFF-R, CD19, and ICOS genes identified as causes of CVID.
• These mutations disrupt the intricate interplay essential for effective humoral immune responses.
• Heterozygous mutations in TACI are frequently observed, necessitating further study of their pathogenic role.

Conclusions:

• The genetic basis of CVID is highly variable, involving multiple genes.
• Mutations in TACI, BAFF-R, CD19, and ICOS contribute to CVID, accounting for 10-15% of cases.
• Further genetic defects are likely to be discovered, underscoring the complexity of CVID pathogenesis.